11 CAN GH TREATMENT IMPROVE THE FINAL HEIGHT OF CHILDREN WITH NON-GHD SHORT STATURE?
スポンサーリンク
概要
著者
-
Igarashi Y
Gh Treatment Study Committee Foundation For Growth Science
-
Tanaka T
Division Of Endocrinology And Metabolism Adolescent Medicine National Center For Child Health And De
-
Tanaka T
National Center for Child Health and Development
-
YOKOYA S
Toranomon Hospital
-
Tanaka T
GH Treatment Study Committee, The Foundation for Growth Science
-
Yokoya S
GH Treatment Study Committee, The Foundation for Growth Science
-
Fujieda K
GH Treatment Study Committee, The Foundation for Growth Science
-
Shimatsu A
GH Treatment Study Committee, The Foundation for Growth Science
-
Tachibana K
GH Treatment Study Committee, The Foundation for Growth Science
-
Tanaka H
GH Treatment Study Committee, The Foundation for Growth Science
-
Tanizawa T
GH Treatment Study Committee, The Foundation for Growth Science
-
Teramoto A
GH Treatment Study Committee, The Foundation for Growth Science
-
Nisi Y
GH Treatment Study Committee, The Foundation for Growth Science
-
Hasegawa Y
GH Treatment Study Committee, The Foundation for Growth Science
-
Hanew K
GH Treatment Study Committee, The Foundation for Growth Science
-
Hizuka N
GH Treatment Study Committee, The Foundation for Growth Science
-
Naiki Y
Division Of Endocrinology And Metabolism Adolescent Medicine National Center For Child Health And De
-
Hanew K
Hanew Endocrine Clinic
-
Hizuka N
Gh Treatment Study Committee The Foundation For Growth Science
-
Shimatsu A
Gh Treatment Study Committee The Foundation For Growth Science
-
Nakagomi Y
Yamanashi University School Of Medicine
-
Teramoto A
Gh Treatment Study Committee The Foundation For Growth Science
-
Tachibana K
Kanagawa Children's Medical Center
-
Hasegawa Y
Tokyo Metropolitan Kiyose Children's Hospital
-
Yokoya S
Gh Treatment Study Committee The Foundation For Growth Science
関連論文
- 55 GROWTH RRESPONSE TO GROWTH HORMONE
- 67 THE ROLE OF KAL1 GENE AND KAL2 GENE (FGFR1) IN KALLMANN SYNDROME : MUTATION ANALYSIS AND CLINICAL ASSESSMENT IN 35 PATIENTS WITH KALLMANN SYNDROME
- 64 ADRENO-GENITO-RENAL DISORDER WITH SEVERE GROWTH FAILURE : A NEW DISEASE
- 77 PTPN11 GENE AND NOONAN/LEOPARD SYNDROME, MUTATIONS ANALYSIS AND COMPARISIONS OF THE CLINlCAL FEATURES OF 45 JAPANESE PATIENTS
- 82 MATERNAL UNIPARENTAL ISODISOMY FOR CHROMOSOME 7 IN A CASE WITH SILVER-RUSSELL SYNDROME
- 132 A CASE OF VIRILIZING ADRENOCORTICAL TUMOR
- 152 Dose an anabolic steroid rescue final heights of gonadal suppression therapy?
- 19 GROWTH HORMONE-RELEASING HORMONE (GHRH) RECEPTOR MUTATION THAT ACTS AS A DOMINANT NEGATIVE.
- 11 CAN GH TREATMENT IMPROVE THE FINAL HEIGHT OF CHILDREN WITH NON-GHD SHORT STATURE?
- 39 TWENTY CHILDREN WITH CUSHING SYNDROME (CS) TREATED IN EIGHT MEDICAL CENTRES
- 34 NOVEL MUTATIONS IN THE CYP11B1 GENE IN JAPANESEPATIENTS WITH CONGENITAL ADRENAL HYPERPLASIA DUE TO 11β-HYDROXYIASE DEFICIENCY
- 52 STUDIES OF HEPATOCYTE NUCLER FACTER-4α HNF4-α AND HNF-1β GENES IN JUVENILE ONSET DIABETES MELLITUS WITHOUT OBESITY
- 69 SKEWED X-INACTIVATION PATTERNS IN THREE FEMALE CARRIERS WITH VASOPRESSIN TYPE 2 RECEPTOR GENE MUTATIONS
- 120 Assessment of psychosocial effect on short-stature children and their families with and without growth hormone therapy
- 125 EFFECT OF ANABOLIC STEROID HORMONE ON GROWTH PROMOTION AND GONADAL FUNCTION IN PUBERTAL BOYS
- Pharmacokinetics and Metabolic Effects of High-Dose Growth Hormone Administration in Healthy Adult Men
- Final Height of Growth Hormone (GH)-Treated Short Children Registered at the Foundation for Growth Science in Japan : Comparison between the Pituitary Human GH Era and the Recombinant Human GH Era
- Registration System for Growth Hormone (GH) Treatment with Standardized Immunoreactive GH Values in Japan
- Clinical Characteristics, Etiologies and Pathophysiology of Patients with Severe Short Stature with Severe GH Deficiency : Questionnaire Study on the Data Registered with the Foundation for Growth Science, Japan
- Studies of Very Severe Short Stature with Severe GH Deficiency : From the Data Registered with the Foundation for Growth Science
- Height Responses in Complete ldiopathic Growth Hormone Deficient Children Less Than Three Years of Age during Growth Hormone Therapy
- Spontaneous Growth in Hormone-Treated Short Children
- Growth Response to Growth Hormone Therapy in Patients with Different Degrees of Growth Hormone Deficiency
- 49 THE CROSS-SECTIONAL BMI GROWTH CURVES FOR JAPANESE FROM BIRTH TO 17 YEARS OF AGE : THE 2000-2001 NATIONAL SURVEY DATA : the comparison with the 1990-1994 data and the 1978-1981 data
- 48 TARGET HEIGHT AND TARGET RANGE FOR THE JAPANESE : REVISITED
- 86 THE AIRE MUTATIONS IN A JAPANESE APECED PATIENT
- 90 MUTATION ANALYSIS IN A JAPANESE KIDRED WITH SPONDYLOEPIPHYSEAL DYSPLASIA TARDA
- 37 WIDE PHENOTYPIC SPECTRUM OF GATA3 HAPLOINSUFFICIENCY : ANALYSIS OF 11 JAPANESE FAMILIES
- 29 TURNER SYNDROME AND XP DELETIONS : CLINICAL AND MOLECULAR STUDIES IN 47 PATIENTS
- 54 Excessive Mid-Growth Spurt (MGS) induced by GH therapy started at early childhood in 3 male siblings with non-endcrine short stature (NESS)
- 16 PREVALENCE OF SHOX HAPLOINSUFFICIENCY IN 900 PATIENTS WITH IDIOPATHIC SHORT STATURE
- 66 URINE 5β/5α-REDUCED STEROID RATIO : INFLUENCE OF MUTAIONS AND POLYMORPHISM OF THE STEROID 5α REDUCTASE-2 GENE
- 106 CLlNICAL DEFINITION OF POLYCYSTIC OVARY SYNDROME(PCOS) IN ADOLESCENCE